Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations
<p>Abstract</p> <p>Background</p> <p>Budesonide has a long history as intranasal drug, with many marketed products. Efforts should be made to demonstrate the therapeutic equivalence and safety comparability between them. Given that systemic availability significantly va...
Main Authors: | Pena Maria, Algorta Jaime, Francisco Silvia, Abajo Zurine, Sanz Emilio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-06-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/9/1/34 |
Similar Items
-
Budesonide Enemas for Topical Therapy of Ulcerative Colitis
by: P Rutgeerts
Published: (1990-01-01) -
Mucoadhesive Budesonide Formulation for the Treatment of Eosinophilic Esophagitis
by: Antonella Casiraghi, et al.
Published: (2020-03-01) -
Esophageal Crohn's Disease Treated “Topically” with Swallowed Aerosolized Budesonide
by: Petros Zezos, et al.
Published: (2010-01-01) -
Investigation into Alternative Sugars as Potential Carriers for Dry Powder Formulation of Budesonide
by: Ali Nokhodchi, et al.
Published: (2011-08-01) -
Design and Efficacy of Nanogels Formulations for Intranasal Administration
by: Blessing A. Aderibigbe, et al.
Published: (2018-05-01)